Effect of kremezin on early-phase renal dysfunction during treatment with cyclosporin A in systemic autoimmune diseases.
M
M
Okada
K
K
Suzuki
M
M
Matsumoto
K
K
Takada
M
M
Nakashima
T
T
Nakanishi
H
H
Horikoshi
T
T
Higuchi
Y
Y
Hosono
F
F
Ohsuzu
D000368:Aged; D001327:Autoimmune Diseases / Q000188:drug therapy; D002244:Carbon / Q000008:administration & dosage / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010087:Oxides / Q000008:administration & dosage / Q000627:therapeutic use*
D010087:Oxides; D002244:Carbon; D016572:Cyclosporine; C040896:AST 120; D003404:Creatinine